UK markets open in 2 hours 26 minutes

MERCK Kommanditgesellschaft auf Aktien (0O14.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
165.57-0.32 (-0.20%)
At close: 06:07PM BST
Full screen
Previous close165.90
Bid163.85 x 0
Ask167.30 x 0
Day's range165.20 - 168.24
52-week range153.10 - 231.30
Avg. volume300,883
Market cap71.902B
Beta (5Y monthly)0.56
PE ratio (TTM)22.59
EPS (TTM)7.33
Earnings dateN/A
Forward dividend & yield1.85 (1.12%)
Ex-dividend date25 Apr 2022
1y target estN/A
  • Reuters

    Germany's Merck to open semiconductor base in China

    German supplier of chemicals and materials used in making semiconductors, Merck KGaA, said on Tuesday it had signed a contract to open a semiconductor base in the Chinese city of Zhangjiagang, describing it as its largest single electronics business investment in the country. The new 69-acre base will house production plants for thin film materials and electronic specialty gasses, warehouses, and operation centers.

  • Reuters

    Merck KGaA preparing sale of pigment business -Handelsblatt

    FRANKFURT (Reuters) -German diversified group Merck KGaA is preparing to put its pigments business up for sale to fund investments at its drugs and electronic chemicals divisions, daily Handelsblatt reported on Monday. The business, which is known as Surface Solutions, could be valued at close to 1 billion euros ($1.08 billion) in a transaction, the newspaper citied people familiar with the matter as saying. Surface Solutions, which makes pigments for a pearlescent or metallic shine in coatings, plastics and cosmetics, is part of Merck's Electronics division, which mainly makes chemicals for semiconductor production as well as liquid crystals and organic light emitting diodes for display screens.

  • Reuters

    Merck KGaA predicts strong earnings growth on lab demand

    FRANKFURT (Reuters) -Germany's Merck KGaA expects strong earnings growth this year as its laboratory gear division benefits from drugmakers' efforts to explore new biotechnologies, even as demand related to COVID-19 has probably reached its peak. "Life Science will remain the strongest growth engine for Merck," said the company, which also makes pharmaceuticals and speciality chemicals for semiconductor manufacturers. Fourth-quarter adjusted EBITDA rose 17.6% to 1.46 billion euros ($1.62 billion), slightly below an analyst consensus of 1.48 billion euros posted on Merck's website.